HRH4 and neoplasm: In vivo experiments on M1/15 human primary melanoma experimental model demonstrated that mice receiving histamine or clozapine (H4R agonist) showed an increased median survival associated to a decrease in tumor growth and intratumoral neovascularization [8, 9].